• PTC Therapeutics Chief Business Officer Eric Pauwels sold 21,277 common shares on June 10 at USD 75.
• He exercised options for 17,566 shares at USD 18.01 on the same day.
• He held 73,411 common shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001323212-26-000010), on June 12, 2026, and is solely responsible for the information contained therein.